Drugs / DC vaccination for postremission therapy in AML
DC vaccination for postremission therapy in AML
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01734304 | Nov 2013 → Mar 2018 | acute myeloid leukemia | Ludwig-Maximilians - University of Munich | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC vaccination for postremission therapy in AML | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01734304 ↗ |
| Modality | Vaccine | “DC vaccination” NCT01734304 ↗ |